A retrospective evaluation of the effectiveness of a targeted medicines use review service in improving asthma and COPD control provided by community pharmacists in England

Abstract Objective Medicines Use Reviews (MUR) may benefit asthma and chronic obstructive pulmonary disease (COPD) control. The present study evaluates the effect of respiratory-targeted MUR-plus (MUR+) services delivered by community pharmacists on Methods A retrospective analysis MUR+ data in PharmOutcomes database was conducted. All patients receiving Milton Keynes were included. Changes control test (ACT) COPD assessment (CAT) scores analysed. Key findings total 191 81 received MUR+. Asthma improved as shown increase mean ACT [+1.2 (95% CI, 0.6–1.8)] decrease CAT [−0.2 −1.4 to 1.0)]. Baseline ACT, smoking cessation, absence change drug therapy, patient education, healthcare professional referral, device training baseline score ≤19 associated with but only cessation related change. multivariable regression model comprising aforementioned variables explained 19% variance (P < 0.001). Only (beta = −0.34, P 0.01). CAT, >20 accounted for 12% changes 0.046). No variable significantly Conclusions Respiratory-targeted service improvements among poorer not COPD. Several potentially modifiable factors such education